Last Updated: May 11, 2026

Claims for Patent: 10,064,936

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,064,936

Title:	Mixed allergen compositions and methods for using the same
Abstract:	Mixed allergen compositions of two or more different allergens are provided. In some instances, the mixed allergen compositions include: a nut allergen; an animal allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin. Also provided are methods of administering the mixed allergen compositions to a subject. The mixed allergen compositions find use in a variety of applications, including health maintenance, immune balance, gut balance, immune support, health improvement and therapeutic applications.
Inventor(s):	Nadeau; Kari C. (Los Altos Hills, CA)
Assignee:	The Board of Trustees of the Leland Stanford Junior University (Stanford, CA)
Application Number:	15/048,609
Patent Claims:	1. A mixed allergen composition comprising: a nut allergen selected from the group consisting of a peanut allergen, an almond allergen, a walnut allergen, a cashew allergen, a hazelnut allergen, a pecan allergen and a pistachio allergen; an animal allergen selected from the group consisting of a shrimp allergen, a cod allergen, and a salmon allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin, wherein the composition comprises equal parts by weight of the nut allergen, the animal allergen, and the non-nut plant allergen, if present. 2. The mixed allergen composition of claim 1, wherein the composition comprises the non-nut plant allergen. 3. The mixed allergen composition of claim 1, wherein the composition comprises the biotic agent. 4. The mixed allergen composition of claim 3, wherein the biotic agent comprises a probiotic. 5. The mixed allergen composition of claim 3, wherein the biotic agent comprises a prebiotic. 6. The mixed allergen composition of claim 1, wherein the composition comprises the vitamin. 7. The mixed allergen composition of claim 1, wherein the composition comprises the non-nut plant allergen, and the vitamin. 8. The mixed allergen composition of claim 1, wherein the amount of each allergen present in the composition ranges from 15 to 99.9 wt. %. 9. The mixed allergen composition of claim 1, wherein the composition further comprises a physiologically acceptable delivery vehicle. 10. The mixed allergen composition of claim 9, wherein the physiologically acceptable delivery vehicle is an ingestible delivery vehicle. 11. The mixed allergen composition of claim 9, wherein the physiologically acceptable delivery vehicle is a topical delivery vehicle. 12. The mixed allergen composition of claim 9, wherein the physiologically acceptable delivery vehicle is an injectable delivery vehicle. 13. A method of treating an allergy in a human subject in need thereof, the method comprising administering the mixed allergen composition of claim 1 to the subject. 14. The method of claim 13, wherein the subject is a juvenile. 15. The method of claim 13, wherein the subject is an adult. 16. The method of claim 15, wherein the subject is pregnant with a fetus or suckling an infant. 17. The mixed allergen composition of claim 1, wherein the non-nut plant allergen is selected from the group consisting of a wheat allergen, a sesame allergen, and an oat allergen. 18. The mixed allergen composition of claim 1, wherein the composition further comprises an animal allergen selected from the group consisting of a chicken egg allergen, a cow milk allergen, and a crab allergen. 19. The mixed allergen composition of claim 1, wherein the mixed allergen composition further comprises a soy allergen. 20. The mixed allergen composition of claim 1, wherein the vitamin is selected from the group consisting of vitamin D and vitamin C. 21. The mixed allergen composition of claim 20, wherein the vitamin is vitamin D. 22. The method of claim 13, wherein the allergy is a food allergy. 23. The method of claim 22, wherein the allergy is a single food allergy. 24. The method of claim 22, wherein the allergy is a multiple food allergy.

Details for Patent 10,064,936

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Aimmune Therapeutics, Inc.	PALFORZIA	peanut (arachis hypogaea) allergen powder-dnfp	Powder	125696	January 31, 2020	10,064,936	2036-02-19
Novo Nordisk Inc.	XULTOPHY 100/3.6	insulin degludec and liraglutide	Injection	208583	November 21, 2016	10,064,936	2036-02-19
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,064,936

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016134291	⤷ Start Trial
United States of America	9731003	⤷ Start Trial
United States of America	2023218749	⤷ Start Trial
United States of America	2022241404	⤷ Start Trial
United States of America	2022133882	⤷ Start Trial
United States of America	2022080041	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.